Clinical Trials Directory

Trials / Completed

CompletedNCT03667235

10 Versus 20 Minutes Treatment of Human Pericardium With Glutaraldehyde in OZAKI Procedure

Status
Completed
Phase
Study type
Observational
Enrollment
6 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To compare mechanic and thermic stability of pericardium fixated either with 0.6% glutaraldehyde for 10 minutes or with 0.6% glutaraldehyde for 20 minutes

Detailed description

Autologous pericardium for aortic valve reconstruction is treated with 0.6% glutaraldehyde for 10 minutes to improve stability (OKAZI technique). This study investigates whether treatment with 0.6% glutaraldehyde for 20 minutes improves mechanic and thermic stability of autologous pericardial tissue. Autologous pericardium remaining after aortic valve reconstruction surgery is used. To investigate 10 versus 20 minutes treatment of removed original aortic valve tissue with glutaraldehyde as a reference.

Conditions

Interventions

TypeNameDescription
OTHERTreatment of human pericardium with glutaraldehyde in OZAKI procedure10 versus 20 minutes treatment of human pericardium with 0.6% glutaraldehyde in OZAKI procedure
OTHERTreatment of human aortic valve tissue with glutaraldehyde10 versus 20 minutes treatment of human aortic valve tissue with 0.6%glutaraldehyde

Timeline

Start date
2017-08-04
Primary completion
2019-10-31
Completion
2019-10-31
First posted
2018-09-12
Last updated
2019-12-10

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03667235. Inclusion in this directory is not an endorsement.